Efficacy and Safety of Vildagliptin, Sitagliptin, and Linagliptin as Add-on Therapy in Chinese Patients with T2DM Inadequately Controlled with Dual Combination of Insulin and Traditional Oral Hypoglycemic Agent

被引:0
|
作者
Ni, Chang-Lin
Tang, Yun-Zhao
Wang, Gang
Jiang, Zhen-Huan
Yan, Tian-Tian
Yang, Min
Chen, Yi-Jun
Meng, Ling-Ling
Zhu, Yan-Juan
Li, Chen-Guang
Li, Zhu
Yu, Ping
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1151-P
引用
收藏
页码:A302 / A302
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent
    Yun-Zhao Tang
    Gang Wang
    Zhen-Huan Jiang
    Tian-Tian Yan
    Yi-Jun Chen
    Min Yang
    Ling-Ling Meng
    Yan-Juan Zhu
    Chen-Guang Li
    Zhu Li
    Ping Yu
    Chang-Lin Ni
    [J]. Diabetology & Metabolic Syndrome, 7
  • [2] Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent
    Tang, Yun-Zhao
    Wang, Gang
    Jiang, Zhen-Huan
    Yan, Tian-Tian
    Chen, Yi-Jun
    Yang, Min
    Meng, Ling-Ling
    Zhu, Yan-Juan
    Li, Chen-Guang
    Li, Zhu
    Yu, Ping
    Ni, Chang-Lin
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2015, 7
  • [3] Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents
    Li, Chun-Jun
    Liu, Xiao-Juan
    Bai, Lian
    Yu, Qian
    Zhang, Qiu-Mei
    Yu, Pei
    Yu, De-Min
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
  • [4] Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents
    Chun-Jun Li
    Xiao-Juan Liu
    Lian Bai
    Qian Yu
    Qiu-Mei Zhang
    Pei Yu
    De-Min Yu
    [J]. Diabetology & Metabolic Syndrome, 6
  • [5] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
    Fonseca, Vivian
    Dejager, Sylvie
    Albrecht, Diego
    Shirt, Lynda
    Schweizer, Anja
    [J]. DIABETES, 2006, 55 : A111 - A111
  • [6] Safety and efficacy of linagliptin as add-on therapy to a sulphonylurea in inadequately controlled type 2 diabetes
    Lewin, A. J.
    Arvay, L.
    Liu, D.
    Patel, S.
    Woerle, H. -J.
    [J]. DIABETOLOGIA, 2010, 53
  • [7] The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Diamant, Michaela
    Schernthaner, Guntram
    Lebovitz, Harold E.
    Inzucchi, Silvio E.
    Bailey, Clifford J.
    [J]. DIABETES CARE, 2014, 37 (07) : 1924 - 1930
  • [8] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
    Du, Jin
    Liang, Li
    Fang, Hui
    Xu, Fengmei
    Li, Wei
    Shen, Liya
    Mu, Yiming
    [J]. DIABETES, 2016, 65 : A293 - A293
  • [9] Efficacy and Safety Comparison of Add-on Therapy with Liraglutide, Saxagliptin and Vildagliptin, All in Combination with Current Conventional Oral Hypoglycemic Agents Therapy in Poorly Controlled Chinese Type 2 Diabetes
    Li, C. -J.
    Yu, Q.
    Yu, P.
    Zhang, Q. -M.
    Ding, M.
    Liu, X. -J.
    Yu, D. -M.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (08) : 469 - 476
  • [10] Safety and Efficacy of Ertugliflozin in Combination with Sitagliptin in Subjects with T2DM Inadequately Controlled on Diet and Exercise: The VERTIS SITA Trial
    Lauring, Brett
    Miller, Sam S.
    Krumins, Tania
    Zhou, Hao Jin
    Huyck, Susan
    Johnson, Jeremy
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    [J]. DIABETES, 2017, 66 : A319 - A320